Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23812 | 279 | 45.2 | 77% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DARPP 32 | Author keyword | 16 | 24% | 20% | 56 |
2 | PPP1R1B | Author keyword | 6 | 80% | 1% | 4 |
3 | ARPP 21 | Author keyword | 4 | 67% | 1% | 4 |
4 | PP1 INHIBITOR | Author keyword | 1 | 50% | 1% | 2 |
5 | T DARPP | Author keyword | 1 | 100% | 1% | 2 |
6 | INTEGRAT BIOSYST | Address | 1 | 16% | 2% | 5 |
7 | KLINIKUM MUNCHEN OST | Address | 1 | 33% | 1% | 2 |
8 | MOLEC CELLULAR NEUROSCI | Address | 1 | 33% | 1% | 2 |
9 | 32 KDA | Author keyword | 1 | 50% | 0% | 1 |
10 | ADENYLYL CYCLASE TYPE VII | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DARPP 32 | 16 | 24% | 20% | 56 | Search DARPP+32 | Search DARPP+32 |
2 | PPP1R1B | 6 | 80% | 1% | 4 | Search PPP1R1B | Search PPP1R1B |
3 | ARPP 21 | 4 | 67% | 1% | 4 | Search ARPP+21 | Search ARPP+21 |
4 | PP1 INHIBITOR | 1 | 50% | 1% | 2 | Search PP1+INHIBITOR | Search PP1+INHIBITOR |
5 | T DARPP | 1 | 100% | 1% | 2 | Search T+DARPP | Search T+DARPP |
6 | 32 KDA | 1 | 50% | 0% | 1 | Search 32+KDA | Search 32+KDA |
7 | ADENYLYL CYCLASE TYPE VII | 1 | 50% | 0% | 1 | Search ADENYLYL+CYCLASE+TYPE+VII | Search ADENYLYL+CYCLASE+TYPE+VII |
8 | BIOCHEMICAL SYSTEMS ANALYSIS | 1 | 50% | 0% | 1 | Search BIOCHEMICAL+SYSTEMS+ANALYSIS | Search BIOCHEMICAL+SYSTEMS+ANALYSIS |
9 | DOPAMINE AND CAMP REGULATED PHOSPHOPROTEIN | 1 | 50% | 0% | 1 | Search DOPAMINE+AND+CAMP+REGULATED+PHOSPHOPROTEIN | Search DOPAMINE+AND+CAMP+REGULATED+PHOSPHOPROTEIN |
10 | DOPAMINE AND CAMP REGULATED PHOSPHOPROTEIN 32 | 1 | 50% | 0% | 1 | Search DOPAMINE+AND+CAMP+REGULATED+PHOSPHOPROTEIN+32 | Search DOPAMINE+AND+CAMP+REGULATED+PHOSPHOPROTEIN+32 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INNERVATED BRAIN REGIONS | 35 | 43% | 23% | 63 |
2 | ADENOSINE 3 5 MONOPHOSPHATE REGULATED PHOSPHOPROTEIN | 20 | 45% | 12% | 34 |
3 | REGULATED NEURONAL PHOSPHOPROTEIN | 17 | 75% | 4% | 12 |
4 | CAMP REGULATED PHOSPHOPROTEIN | 10 | 30% | 10% | 27 |
5 | T DARPP | 9 | 67% | 3% | 8 |
6 | NEURONAL PHOSPHOPROTEIN | 8 | 39% | 5% | 15 |
7 | AMP REGULATED PHOSPHOPROTEIN | 6 | 48% | 4% | 10 |
8 | DARPP 32 | 6 | 16% | 13% | 36 |
9 | 3 5 MONOPHOSPHATE REGULATED NEURONAL PHOSPHOPROTEIN | 3 | 57% | 1% | 4 |
10 | PHOSPHATASE 1 CASCADE | 2 | 36% | 2% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Neuroscience - The neurobiology of slow synaptic transmission | 2001 | 444 | 39 | 46% |
DARPP-32: An integrator of neurotransmission | 2004 | 304 | 117 | 30% |
DARPP-32, jack of all trades ... master of which? | 2011 | 23 | 150 | 43% |
Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases | 2011 | 17 | 151 | 47% |
DARPP-32: molecular integration of phosphorylation potential | 2008 | 17 | 26 | 46% |
Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder | 2007 | 28 | 12 | 42% |
Signaling in Striatal Neurons: The Phosphoproteins of Reward, Addiction, and Dyskinesia | 2012 | 6 | 167 | 23% |
Beyond the dopamine receptor: the DARPP-32/Protein phosphatase-1 cascade | 1999 | 437 | 104 | 17% |
An association study between PPPlRlB gene and schizophrenia in the Chinese population | 2007 | 11 | 22 | 41% |
THERAPEUTIC TARGETING OF "DARPP-32": A KEY SIGNALING MOLECULE IN THE DOPIMINERGIC PATHWAY FOR THE TREATMENT OF OPIATE ADDICTION | 2009 | 12 | 44 | 23% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTEGRAT BIOSYST | 1 | 16% | 1.8% | 5 |
2 | KLINIKUM MUNCHEN OST | 1 | 33% | 0.7% | 2 |
3 | MOLEC CELLULAR NEUROSCI | 1 | 33% | 0.7% | 2 |
4 | CHAIR MATH THEORY COMPLEX SYST | 1 | 50% | 0.4% | 1 |
5 | COGNIT NEUROPSYCHIAT GRPNEUROIMAGING NIC | 1 | 50% | 0.4% | 1 |
6 | GENES COGNIT PSYCHOSIS PROGRAM INTRAMURAL R | 1 | 50% | 0.4% | 1 |
7 | HEIDELBERG AMER STUDIES | 1 | 50% | 0.4% | 1 |
8 | MOL CYTOGENET S | 1 | 50% | 0.4% | 1 |
9 | NEUROSCI PHYSIOL NEUROSCI | 1 | 50% | 0.4% | 1 |
10 | PHARMACEUT SCI NEUROL | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000180914 | CASEIN KINASE 1//CK1 DELTA//CK1 EPSILON |
2 | 0.0000163286 | SKF83959//SKF 83959//TOPOGRAPHICAL ASSESSMENT |
3 | 0.0000136251 | PROTEIN PHOSPHATASE 1//INHIBITOR 2//GLYCOGEN SYNTHASE |
4 | 0.0000132622 | CIAPIN1//NOB1//MG7 AG |
5 | 0.0000121218 | DELAY PERIOD ACTIVITY//CORT CIRCUITS COMPUTAT//HIGH TECH CHIYODA KU |
6 | 0.0000120200 | CDK5//P35//CYCLIN DEPENDENT KINASE 5 |
7 | 0.0000111983 | TONICALLY ACTIVE NEURONS//NEOSTRIATUM//THALAMOSTRIATAL PROJECTIONS |
8 | 0.0000095584 | SYNAPSINS//SYNAPSIN//SYNAPSIN III |
9 | 0.0000067819 | ADENOSINE A2A RECEPTOR//ADENOSINE A2A RECEPTORS//ISTRADEFYLLINE |
10 | 0.0000065903 | REINSTATEMENT//SELF ADMINISTRATION//BEHAV NEUROSCI BRANCH |